Military Shopping Channel to Offer CellerateRX to Its 10M+ Eligible Members; WNDM Product Sales on Military Site to Commence September 1, 2011

FORT WORTH, Texas, Sept. 1, 2011 /PRNewswire/ -- Wound Management Technologies, Inc., (OTCQB: WNDM; WNDM.PK) a leader in advanced wound care solutions, today announced that the Military Shopping Channel (MSC), an exclusive online retailer specializing in products for active and retired Military Personnel and their Families, has agreed to offer CellerateRX® as a featured product within its shopping service.  MSC, owned in part by Kevin Harrington, the Chairman of direct response marketing company H&H Imports and one of the celebrity judges on the TV series Shark Tank, is launching the service on September 1st exclusively to over 10 million eligible servicemen and women, military dependants and military retirees.

CellerateRX gel orders from the Military Shopping Channel will be filled by Marketing Media Enterprizes, LLC (MME), an Orlando, Florida medical products distributor of Wound Care Innovations products, serving the direct-to-consumer and military markets.

To launch the sales and marketing campaign, MSC will link customers to its Website where CellerateRX will be featured in the Health and Fitness section under sub-categories First Aid, Wellness and As Seen on TV.

Scott Haire, Chairman & CEO of Wound Management Technologies commented on the significance of the event, "We are pleased and proud that our advanced wound care product is being offered to a segment of our population that has given our country so much.  CellerateRX is easy to apply, FDA cleared for use on all wounds except 3rd degree burns, and it is cost effective.  This can be an ideal product for active service personnel and veterans who need to manage their wounds at home or in the field."

View The Military Shopping Channel's final preparations for the September 1, 2011 launch of its shopping channel where it proudly displays the "amazing wound care product" called CellerateRX.  http://www.youtube.com/mscinsider#p/c/7DB4A74CBE681F1E/6/ApG-Y6u34Pk

About Wound Management Technologies, Inc.

Wound Management Technologies, Inc. is an emerging commercial stage company with its primary products in the $5B worldwide advanced wound care market. Wound Management's primary focus is the distribution of its unique, patented collagen product, CellerateRX®, which is FDA cleared and reimbursable under Medicare Part B. Wound Management has other advanced biotech products in development including a patented resorbable bone wax line that is in late stages of development, as well as a subsidiary focused on technology for secure healthcare data collaboration and storage.  More information can be found on the company's web sites: http://www.wmgtech.com and http://www.celleraterx.com.

Follow us on: FACEBOOK | TWITTER | LINKEDIN

Safe Harbor Statement:

The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development and any other statements not constituting historical facts are "forward-looking statements," within the meaning of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks, contingencies and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties detailed in the Company's SEC filings, which could cause the company's actual operating results, performance or business plans or prospects to differ materially from those expressed in, or implied by these statements. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.

For Wound Management Technologies Shareholder Information please call (917) 974-9872 or visit http://www.wmgtech.com

SOURCE Wound Management Technologies, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED